Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
CDMO
Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)
PR-M01-24-01
CDMO
Vetter joins Science Based Targets Initiative
PR-M12-23-01
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
PR-M10-23-03
CDMO Service and Capacity Expansion
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
PR-M05-23-01
UN Global Compact
CDMO Joins United Nations Global Compact
PR-M03-23-02
Clinical Manufacturing
Vetter's Clinical Facility Demonstrates Success with Five Client Products Now on the Market
PR-M01-23-01
Warehouse Storage
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
PR-M10-22-07
Site Expansion
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
PR-M06-22-07
Award
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award
PR-M05-22-12
Lab Benchmarking
Top Results for Vetter in University of St. Gallen Benchmarking
PR-M04-22-04
Strategic Alliance
Rentschler Biopharma and Vetter Unveil Xpert Alliance
PR-M03-22-14
Manufacturing Authorization
Vetter’s New Clinical Manufacturing Site Now Officially Authorized
PR-M01-22-12
Climate Protection
Vetter's Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral
PR-M09-21-06
Clinical Manufacturing
Vetter's New Clinical Manufacturing Site Now Fully Integrated
PR-M07-21-011
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
PAO-06-21-CL-02
Award
Vetter Once Again Wins Axia Best Managed Companies Award
PR-M05-21-019
Vetter
Vetter and Rentschler Biopharma Further Strengthen Their Strategic Alliance
PR-M04-21-028
Sustainability
Vetter Continues to Implement its Long-Term Sustainability Strategy
PR-M11-20-029
Strategy
Vetter Continues its Long-term Investment Strategy to Sustain Future Growth
PR-M10-20-13
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
PAP-Q3-20-CL-028
Sustainability
Vetter Achieves Carbon Dioxide-Neutral Levels
PR-M07-20-NI-42
Capacity Expansion
Vetter Further Expands its Development Service with New Site in Austria
PR-M07-20-NI-010
Collaboration
The Key to Tackling Drug Development Complexity: Collaboration
PR-M07-20-NI-005
Award
Vetter Wins Axia Best Managed Companies Award
PR-M05-20-NI-039
Lab Portfolio
Vetter Aligns its Development Service Laboratory Portfolio Under One Roof
PR-M01-20-NI-043
AI
Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work
PR-M10-19-NI-045
Tech Transfer
Realizing Technology Transfer in a Successful and Sustainable Manner
PAP-Q3-19-CL-035
Award
Vetter’s Chicago Site Wins Award ‘One of Best and Brightest Companies to Work For®
PR-M09-19-NI-046
CDMO
Aspects to Consider on the Way to a Tailored Manufacturing Strategy
PAP-Q3-18-CL-005
Drug Delivery
Supporting Parenteral Development and Manufacturing with End-to-End Services
PAP-Q1-18-CL-014
Packaging
Vetter Begins Construction of Packaging Facility Expansion
PAO-M12-17-NI-011
Recognition
Vetter receives Corporate Health Award’s recognition of excellence
PR-M12-17-NI-001
Drug Delivery
Vetter and Microdermics Will Develop Microneedle Delivery Systems
PAO-M06-17-NI-008